A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic Rhinitis

Clinical trial NCT02279563 · UNKNOWN

Trial details

NCT number: NCT02279563
Sponsor: Apotex Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2013-12-01
Primary completion: 2014-02-01
Enrollment: 595

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.